Forskolin and phorbol ester have opposite effects on the expression of mucin-associated sialyl-Lewis in pancreatic cancer cells

European Journal of Cancer

Volumn 36, Issue 1, 2000, Pages 113-120

  Yamashita, Y ^a   Ho, J J L ^b   Farrelly, E R ^b   Hirakawa, K ^a   Sowa, M ^a   Kim, Y S ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cAMP; E selectin; Mucin; Pancreas; Phorbol ester; Sialyl Lewisa

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DACTINOMYCIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FORSKOLIN; MEMBRANE ANTIGEN; MUCIN; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER;

ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CA-15-3 ANTIGEN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DACTINOMYCIN; FORSKOLIN; HUMANS; OLIGOSACCHARIDES; PANCREATIC NEOPLASMS; PHORBOL ESTERS; PROTEIN KINASE C; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033985877     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00238-5     Document Type: Article

References (24)

1. Magnani J., Steplewski Z., Koprowski H., Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 43:1983;5489-5492.
2. Chung Y.S., Nakata B., Sawada T.et al. New radioimmunoassay for pancreatic cancer-associated antigen SPan-1 with reference to differential diagnosis and monitoring in pancreatic cancer. Int. J. Oncol. 2:1993;921-926.
3. Ho J.J.L., Chung Y.S., Fujimoto Y.et al. Mucin-like antigens in a human pancreatic cancer cell line identified by murine monoclonal antibodies SPan-1 and YPan-1. Cancer Res. 48:1988;3924-3931.
4. Ho J.J.L., Kim Y.S. Do mucins promote tumour cell metastasis? Int. J. Oncol. 7:1995;913-926.
5. a antigen Int. J. Cancer. 69:1996;290-294.
6. Sawada T., Ho J.J.L., Chung Y.S., Sowa M., Kim Y.S. E-selectin binding by pancreatic tumour cells is inhibited by cancer sera. Int. J. Cancer. 57:1994;901-907.
7. Schlechte W., Brattain M., Boyd D. Dependence on urokinase receptor display. Cancer Commun. 2:1990;173-179.
8. Glass D.B., Cheng H.C., Mende-Mueller L., Reed J., Walsh D.A. Primary structure determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J. Biol. Chem. 264:1989;8802-8810.
9. Smith M.K., Colbran R.J., Soderling T.R. Specificities of autoinhibitory domain peptides for four protein kinases. J. Biol. Chem. 265:1990;1837-1890.
10. Ligtenberg M.J.L., Vos H.L., Gennissen A.M.C., Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. Biol. Chem. 265:1990;5573-5578.
11. x and other lacto-series type 2 chain antigens. absence of reactivity with normal hematopoietic progenitor cells Blood. 79:1992;713-719.
12. x with MUC-1 apomucin in a pancreatic cell line. Cancer Res. 55:1995;3659-3663.
13. Ho J.J.L., Bi N., Siddiki B., Chung Y.S., Yuan M., Kim Y.S. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line. Cancer Res. 53:1993;884-890.
14. Yamashita Y., Ho J.J.L., Cheng S.et al. Expression of mucin-associated tumour antigens is altered by cell density. Int. J. Cancer. 72:1997;1-10.
15. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 23:1984;5036-5041.
16. Magnani J.L., Nilsson B., Brockhaus M.et al. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J. Biol. Chem. 257:1982;14365-14369.
17. Boshell M., Lalani E-N., Pemberton L., Burchell J., Gendler S., Taylor-Papadimitriou J. The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tail. Biochem. Biophys. Res. Commun. 185:1992;1-8.
18. Mangkharak J., Patanachak C., Podhisuwan K., Pleechachinda R. The evaluation of combined scintimammography and tumour markers in breast cancer patients. Anticancer Research. 17:1997;1611-1614.
19. Arribas J., Coodly L., Vollmer P., Kishimoto T.K., Rose-John S., Massague J. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271:1996;11376-11382.
20. Knibbs R.N., Craig R.A., Natsuka S.et al. The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells. J. Cell. Biol. 133:1996;911-920.
21. Yamashita Y., Hirakawa K., Ho J.J.L.et al. Forskolin increases the sensitivity of CA19-9 in the early diagnosis of pancreatic cancer. Proc. Am. Assoc. Cancer Res. 39:1998;50.
22. Ho J.J.L., Farrelly E.R., Logvinova A., Kwan J., Kim Y.S. Regulation of the pancreatic tumour antigen Nd2 by cyclic AMP, phorbol ester, secretin, and VIP. Gastroenterology. 112:1997;A449.
23. 111In-labeled monoclonal antibody Nd2 in patients with pancreatic cancer. Jpn. J. Cancer Res. 88:1997;427-434.
24. Kondo Y., Chung Y.S., Sawada T.et al. Intratumoral injection of an adriamycin immunoconjugate against human pancreatic cancer xenografts. Jpn. J. Cancer Res. 86:1995;1072-1079.